Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GoBBson Feb 17, 2020 9:45pm
60 Views
Post# 30700729

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:These people here telling you to sell...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:These people here telling you to sell...
Oh I completely agree aussyspitz  ... I only posted that to clear the air on what they have communicated. Its all about what they actually achieve not what they say.  They use the forwarding looking statements/risks clauses to completely exonerate themselves ahead of time anyway. barf.
<< Previous
Bullboard Posts
Next >>